These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ. Gracia M; Martínez-Marín C; Huelves L; Giménez MJ; Aguilar L; Carcas A; Ponte C; Soriano F Antimicrob Agents Chemother; 2005 Mar; 49(3):996-1001. PubMed ID: 15728894 [TBL] [Abstract][Full Text] [Related]
44. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae. Esposito S; Noviello S; Ianniello F Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809 [TBL] [Abstract][Full Text] [Related]
45. Treatment of pneumococcal pneumonia. Pallares R Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315 [TBL] [Abstract][Full Text] [Related]
46. Determination of penicillin resistance in Streptococcus pneumoniae and use of co-trimoxazole in treatment of pneumococcal pneumoniae. Lalitha MK; Manoharan A; Pai R; Thomas K J Clin Microbiol; 1999 Aug; 37(8):2743-4. PubMed ID: 10447408 [No Abstract] [Full Text] [Related]
47. The incidence of penicillin-resistant pneumococci in the Slovak Republic. Pneumococcus Study Group. Trupl J; Hupková H; Appelbaum PC; Jacobs MR Chemotherapy; 1997; 43(5):316-22. PubMed ID: 9309364 [TBL] [Abstract][Full Text] [Related]
48. Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains. Musher DM Infect Dis Clin North Am; 1991 Sep; 5(3):509-21. PubMed ID: 1955697 [TBL] [Abstract][Full Text] [Related]
49. Does penicillin remain the drug of choice for pneumococcal pneumonia in view of emerging in vitro resistance? Chiou CC Clin Infect Dis; 2006 Jan; 42(2):234-7. PubMed ID: 16355334 [No Abstract] [Full Text] [Related]
50. Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae. van Rensburg D; Fogarty C; De Salvo MC; Rangaraju M; Nusrat R J Infect; 2005 Oct; 51(3):201-5. PubMed ID: 16230216 [TBL] [Abstract][Full Text] [Related]
51. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968 [TBL] [Abstract][Full Text] [Related]
52. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438 [TBL] [Abstract][Full Text] [Related]
53. Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Drelichman V; Cushing RD; Bawdon RE; Lerner AM Am J Med Sci; 1984; 287(3):39-43. PubMed ID: 6610355 [TBL] [Abstract][Full Text] [Related]
54. Antibiotic-resistant pneumococcal pneumonia. Feldman C; Klugman K S Afr Med J; 1996 Jan; 86(1):28-30. PubMed ID: 8685776 [No Abstract] [Full Text] [Related]
55. Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy. Nuermberger E; Helke K; Bishai WR Int J Antimicrob Agents; 2005 Dec; 26(6):497-503. PubMed ID: 16289711 [TBL] [Abstract][Full Text] [Related]
56. Activity of the new quinolone WCK 771 against pneumococci. Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298 [TBL] [Abstract][Full Text] [Related]
57. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae. Lee WK; Young BW J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621 [No Abstract] [Full Text] [Related]
58. [Resistance to penicillin G and Streptococcus pneumoniae infection at the Hôpital Foch, Paris, France, in 1995]. Mouly S; Couderc LJ; Cahen P; Loirat P; Blétry O; Caubarrère I Ann Med Interne (Paris); 1998 Oct; 149(6):323-5. PubMed ID: 9853040 [TBL] [Abstract][Full Text] [Related]
59. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? Peterson LR Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333 [TBL] [Abstract][Full Text] [Related]
60. [Aminopenicillins verses cephalosporins in the treatment of pneumonia by pneumococci resistant to penicillin: animal model]. Soriano F; Ponte C Med Clin (Barc); 1998 Feb; 110 Suppl 1():16-20. PubMed ID: 9717155 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]